Literature DB >> 18415836

Fungal infections in hematopoietic stem cell transplant recipients.

Kieren A Marr1.   

Abstract

Fungal infections have historically been, and remain important causes of transplant-related morbidity in recipients of hematopoietic stem cell transplant (HSCT). However, there have been notable changes in the epidemiology and outcomes of invasive fungal infections, induced by changes in the transplant procedures as well as supportive care. This review discusses invasive fungal infections in hematopoietic stem cell transplant recipients, with a focus on the host and the two most common infections, candidiasis and those caused by moulds.

Entities:  

Mesh：

Year:  2008        PMID： 18415836     DOI： 10.1080/13693780701885552

Source DB:  PubMed          Journal:  Med Mycol        ISSN： 1369-3786            Impact factor:   4.076


  18 in total

1.  Combined therapy of voriconazole and anidulafungin in murine infections by Aspergillus flavus.

Authors:  Enrique Calvo; F Javier Pastor; Valentina Salas; Emilio Mayayo; Josep Guarro
Journal:  Mycopathologia       Date:  2011-12-04       Impact factor: 2.574

2.  Cerebrovascular disease after allogeneic hematopoietic stem cell transplantation: incidence, risk, and clinical outcome.

Authors:  Ting-An Lin; Jyh-Pyng Gau; Yao-Chung Liu; Po-Shen Ko; Hao-Yuan Wang; Sheng-Hsuan Chien; Chia-Jen Liu; Liang-Tsai Hsiao; Tzeon-Jye Chiou; Jin-Hwang Liu
Journal:  Int J Hematol       Date:  2019-03-12       Impact factor: 2.490

Review 3.  Fungus-Specific CD4 T Cells as Specific Sensors for Identification of Pulmonary Fungal Infections.

Authors:  Alexander Scheffold; Carsten Schwarz; Petra Bacher
Journal:  Mycopathologia       Date:  2017-11-22       Impact factor: 2.574

Review 4.  Risk stratification and immunogenetic risk for infections following stem cell transplantation.

Authors:  Agnieszka Wójtowicz; Pierre-Yves Bochud
Journal:  Virulence       Date:  2016-09-09       Impact factor: 5.882

Review 5.  Invasive fungal infection in haematopoietic stem cell transplant recipients: epidemiology from the transplant physician's viewpoint.

Authors:  E J Bow
Journal:  Mycopathologia       Date:  2009-04-03       Impact factor: 2.574

Review 6.  Efflux-mediated antifungal drug resistance.

Authors:  Richard D Cannon; Erwin Lamping; Ann R Holmes; Kyoko Niimi; Philippe V Baret; Mikhail V Keniya; Koichi Tanabe; Masakazu Niimi; Andre Goffeau; Brian C Monk
Journal:  Clin Microbiol Rev       Date:  2009-04       Impact factor: 26.132

Review 7.  Antifungal drug resistance: do molecular methods provide a way forward?

Authors:  David S Perlin
Journal:  Curr Opin Infect Dis       Date:  2009-12       Impact factor: 4.915

8.  Micafungin in the treatment of invasive candidiasis and invasive aspergillosis.

Authors:  Nathan P Wiederhold; Jason M Cota; Christopher R Frei
Journal:  Infect Drug Resist       Date:  2009-01-12       Impact factor: 4.003

9.  Clinical safety and tolerability issues in use of triazole derivatives in management of fungal infections.

Authors:  Dionissios Neofytos; Edina Avdic; Anna-Pelagia Magiorakos
Journal:  Drug Healthc Patient Saf       Date:  2010-04-20

10.  Invasive fungal infection among hematopoietic stem cell transplantation patients with mechanical ventilation in the intensive care unit.

Authors:  Chen-Yiu Hung; Kuo-Chin Kao; Po-Nan Wang; Han-Chung Hu; Meng-Jer Hsieh; Jui-Ying Fu; Chih-Hao Chang; Li-Fu Li; Chung-Chi Huang; Ying-Huang Tsai; Cheng-Ta Yang
Journal:  BMC Infect Dis       Date:  2012-02-18       Impact factor: 3.090
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.